Cowen Remains Bullish Following Alexion Pharma's (ALXN) 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Alexion Pharma (ALXN) Tops Q3 EPS by 15c; Guides Above Views
October 29, 2015 7:52 AM EDTAlexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $1.16, $0.15 better than the analyst estimate of $1.01. Revenue for the quarter came in at $666.6 million versus the consensus estimate of $668.33 million.
Alexion Pharma sees FY2015 EPS of $4.92-$4.97, versus the consensus of $4.82.
The third... More
UPDATE: Trading Radar for 10/29: Aetna (AET), LinkedIn (LNKD), Baidu (BIDU), ConocoPhillips (COP), MGM Resorts (MGM), Deckers (DECK) Report
October 28, 2015 2:53 PM EDT(Updated - October 28, 2015 2:54 PM EDT)
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
A.H. Belo (NYSE: AHC) - no Street consensus
Aetna (NYSE: AET) - consensus EPS $1.77
Air Products (NYSE: APD) -... More
Baird Remains Bullish on Alexion Pharma (ALXN) as FDA Approves Strensiq
October 27, 2015 9:14 AM EDTBaird reiterated an Outperform rating and $221.00 price target on Alexion Pharmaceuticals (NASDAQ: ALXN) following Strensiq's FDA approval for hypophosphatasia. The company plans to use a sales force approximately double that at Soliris launch, to promote both Strensiq and Kanuma (PDUFA: December 8) along with Medical... More
